Unlock instant, AI-driven research and patent intelligence for your innovation.

Entrectinib crystal form and preparation method thereof

A technology of entrectinib and crystal forms, applied in the field of medicinal chemistry, can solve the problems of poor stability of crystal forms, poor solubility of crystal forms 2 and 4, etc.

Active Publication Date: 2022-07-12
JIANGSU CHUANGUO PHARMA CO LTD +2
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Obviously, the existing entrectinib crystal form 1 has the problem of poor crystal stability, and the crystal form 2 and crystal form 4 have the problem of poor solubility

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Entrectinib crystal form and preparation method thereof
  • Entrectinib crystal form and preparation method thereof
  • Entrectinib crystal form and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0226] (3) The preparation process of the crystal form AZT-A is simple, the operability is strong, the yield is high, the quality is stable, the production cycle is short, and it is easy to realize large-scale production.

[0227] (4) Compared with the amorphous form, the crystal form AZT-A is less likely to raise dust, has better stability under high humidity and / or high temperature, is less hygroscopic and has good fluidity, and is suitable for formulation technology.

[0228] Crystal form AZT-B of entrectinib and preparation method thereof

[0229] In a specific embodiment, the crystal form of entrectinib provided by the present invention is crystal form AZT-B.

[0230] In another preferred embodiment, the crystalline form AZT-B is the anhydrate of entrectinib.

[0231] In a specific embodiment, under powder X-ray diffraction, the crystalline form AZT-B has characteristic peaks at 2θ of 7.4±0.2°, 8.1±0.2°, 14.8±0.2°, 17.2±0.2°, 19.9±0.2° .

[0232] In another preferred e...

Embodiment 1

[0467] Preparation of Entratinib Crystal Form AZT-A

Embodiment 1-1

[0469] Mix 2 g of Entratinib crystal form 2 with 10 ml of ethyl acetate, heat to 50°C to dissolve, cool to 10°C, and dry at room temperature to obtain crystal form AZT-A. Its X-ray powder diffraction pattern is as follows figure 1 shown; the obtained solid is tested by TGA and its spectrum is as follows figure 2 As shown; the obtained solid is subjected to DSC test and its spectrum is as follows image 3 shown; the obtained solid was subjected to 1 H-NMR test, its spectrum is as follows Figure 4 shown.

[0470] figure 2 TGA showed that the crystalline form AZT-A lost 0.3% in weight at 30°C-150°C and was anhydrous.

[0471] image 3 DSC showed that the crystalline form AZT-A had the first endothermic peak at 162.5 °C and the second endothermic peak at 196.78 °C.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
strengthaaaaaaaaaa
strengthaaaaaaaaaa
Login to View More

Abstract

The present invention provides a crystal form of entrectinib and a preparation method thereof. Specifically, the present invention provides the crystal form of the compound shown in formula I, and the crystal form is crystal form AZT-A, crystal form AZT-B or crystal form AZT-E. Compared with the existing entrectinib crystal form, the crystal form of the present invention has more excellent solubility, better stability, updated electrostatic effect, simple preparation process, strong operability, high yield, stable quality and short production cycle , easy to achieve large-scale production.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a crystal form of entrectinib and a preparation method thereof. Background technique [0002] Entrectinib, English name Entrectinib, its chemical name: N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazine- 1-yl)-2-((tetrahydro-2H-pyran-4-yl)amino)benzamide, trade name: Rozlytrek, molecular formula: C 31 H 34 F 2 N 6 O 2 , the molecular weight is: 560.64, the CAS number is: 1108743-60-7, and the chemical structural formula is: [0003] [0004] The drug is a disease developed by Roche for the treatment of NTRK fusion-positive advanced or recurrent solid tumors, and was applied for listing in Japan on June 19, 2019. [0005] Patent WO2013174876 discloses crystal form 1, crystal form 2 and crystal form 3 of entrectinib and their preparation methods. Among them, crystal form 1 and crystal form 2 are anhydrous, crystal form 3 is a solvate of ethyl acetate and n...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D405/12A61P35/00A61K31/496
CPCC07D405/12A61P35/00C07B2200/13
Inventor 李庆秋申淑匣张良
Owner JIANGSU CHUANGUO PHARMA CO LTD